A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registry.

MLA

Knapen, L. M., et al. “A Real-Life Study on the Implementation and Effectiveness of Exemestane plus Everolimus per Hospital Type in Patients with Advanced Breast Cancer. A Study of the Southeast Netherlands Advanced Breast Cancer Registry.” Breast (Edinburgh, Scotland), vol. 44, Apr. 2019, pp. 46–51. EBSCOhost, https://doi.org/10.1016/j.breast.2019.01.001.

APA

Knapen, L. M., Geurts, S. M. E., Ibragimova, K. I. E., Croes, S., Vriens, B. E. P. J., van den Berkmortel, F. W. P. J., Dercksen, M. W., van de Wouw, A. J., Pepels, M. J. A. E., de Fallois, A. O. J., Lobbezoo, D. J. A., de Boer, M., & Tjan-Heijnen, V. C. G. (2019). A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registry. Breast (Edinburgh, Scotland), 44, 46–51. https://doi.org/10.1016/j.breast.2019.01.001

Chicago

Knapen, L M, S M E Geurts, K I E Ibragimova, S Croes, B E P J Vriens, F W P J van den Berkmortel, M W Dercksen, et al. 2019. “A Real-Life Study on the Implementation and Effectiveness of Exemestane plus Everolimus per Hospital Type in Patients with Advanced Breast Cancer. A Study of the Southeast Netherlands Advanced Breast Cancer Registry.” Breast (Edinburgh, Scotland) 44 (April): 46–51. doi:10.1016/j.breast.2019.01.001.